{"corpus_id":30447140,"paper_sha":"d4778ca52e386097d42372e9948da62359c69975","doi":"10.3174/ajnr.A4484","arxiv_id":null,"pmid":26338913,"pmcid":"PMC4724408","mag_id":1852426414,"dblp_id":null,"acl_id":null,"title":"T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status","year":2015,"publication_date":"2015-12-01","venue":"American Journal of Neuroradiology","journal":{"name":"American Journal of Neuroradiology","pages":"2256 - 2261","volume":"36"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":32,"citation_count":52,"influential_citation_count":1,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Biomarkers, Tumor","mj":false,"qs":[{"q":"analysis","mj":true,"ui":"Q000032"}],"ui":"D014408"},{"d":"Brain Neoplasms","mj":false,"qs":[{"q":"pathology","mj":true,"ui":"Q000473"}],"ui":"D001932"},{"d":"ErbB Receptors","mj":false,"qs":[{"q":"analysis","mj":true,"ui":"Q000032"}],"ui":"D066246"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Glioblastoma","mj":false,"qs":[{"q":"pathology","mj":true,"ui":"Q000473"}],"ui":"D005909"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Magnetic Resonance Imaging","mj":false,"qs":[{"q":"methods","mj":true,"ui":"Q000379"}],"ui":"D008279"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"ROC Curve","mj":false,"ui":"D012372"},{"d":"Statistics, Nonparametric","mj":false,"ui":"D018709"}],"chemicals":[{"n":"Biomarkers, Tumor","ui":"D014408","reg":"0"},{"n":"epidermal growth factor receptor VIII","ui":"C410723","reg":"0"},{"n":"ErbB Receptors","ui":"D066246","reg":"EC 2.7.10.1"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"http://www.ajnr.org/content/ajnr/36/12/2256.full.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/d4778ca52e386097d42372e9948da62359c69975","s2_open_access_license":"CCBY","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"BACKGROUND AND PURPOSE: Epidermal growth factor receptor variant III is a common mutation in glioblastoma, found in approximately 25% of tumors. Epidermal growth factor receptor variant III may accelerate angiogenesis in malignant gliomas. We correlated T1-weighted dynamic contrast-enhanced MR imaging perfusion parameters with epidermal growth factor receptor variant III status. MATERIALS AND METHODS: Eighty-two consecutive patients with glioblastoma and known epidermal growth factor receptor variant III status who had dynamic contrast-enhanced MR imaging before surgery were evaluated. Volumes of interest were drawn around the entire enhancing tumor on contrast T1-weighted images and then were transferred onto coregistered dynamic contrast-enhanced MR imaging perfusion maps. Histogram analysis with normalization was performed to determine the relative mean, 75th percentile, and 90th percentile values for plasma volume and contrast transfer coefficient. A Wilcoxon rank sum test was applied to assess the relationship between baseline perfusion parameters and positive epidermal growth factor receptor variant III status. The receiver operating characteristic method was used to select the cutoffs of the dynamic contrast-enhanced MR imaging perfusion parameters. RESULTS: Increased relative plasma volume and increased relative contrast transfer coefficient parameters were both significantly associated with positive epidermal growth factor receptor variant III status. For epidermal growth factor receptor variant III–positive tumors, relative plasma volume mean was 9.3 and relative contrast transfer coefficient mean was 6.5; for epidermal growth factor receptor variant III–negative tumors, relative plasma volume mean was 3.6 and relative contrast transfer coefficient mean was 3.7 (relative plasma volume mean, P < .001, and relative contrast transfer coefficient mean, P = .008). The predictive powers of relative plasma volume histogram metrics outperformed those of the relative contrast transfer coefficient histogram metrics (P < = .004). CONCLUSIONS: Dynamic contrast-enhanced MR imaging shows greater perfusion and leakiness in epidermal growth factor receptor variant III–positive glioblastomas than in epidermal growth factor receptor variant III–negative glioblastomas, consistent with the known effect of epidermal growth factor receptor variant III on angiogenesis. Quantitative evaluation of dynamic contrast-enhanced MR imaging may be useful as a noninvasive tool for correlating epidermal growth factor receptor variant III expression and related tumor neoangiogenesis. This potential may have implications for monitoring response to epidermal growth factor receptor variant III–targeted therapies.","claims":[{"public_id":"cl_8ce02f54590e9eb6d47952b01d8b2b6a","status":"active","text":"Dynamic contrast-enhanced MR imaging showed greater perfusion and leakiness in epidermal growth factor receptor variant III-positive glioblastomas than in epidermal growth factor receptor variant III-negative glioblastomas.","confidence":0.94,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_8ce02f54590e9eb6d47952b01d8b2b6a"},{"public_id":"cl_368add52cae08d4c3995debf58300bc4","status":"active","text":"Eighty-two consecutive patients with glioblastoma and known epidermal growth factor receptor variant III status were evaluated with preoperative dynamic contrast-enhanced MR imaging.","confidence":0.96,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_368add52cae08d4c3995debf58300bc4"},{"public_id":"cl_ffc014d16e3d3c48c5a9212d95ce2e1d","status":"active","text":"Epidermal growth factor receptor variant III-positive tumors had higher mean relative plasma volume and mean relative contrast transfer coefficient values than epidermal growth factor receptor variant III-negative tumors.","confidence":0.95,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_ffc014d16e3d3c48c5a9212d95ce2e1d"},{"public_id":"cl_ba49d44d6bd047bd7e12b33a24325562","status":"active","text":"Increased relative plasma volume and increased relative contrast transfer coefficient parameters were significantly associated with positive epidermal growth factor receptor variant III status.","confidence":0.96,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_ba49d44d6bd047bd7e12b33a24325562"},{"public_id":"cl_ccb6a807aac733e7ac9a5015aa8f526a","status":"active","text":"Relative plasma volume histogram metrics had greater predictive power for epidermal growth factor receptor variant III status than relative contrast transfer coefficient histogram metrics.","confidence":0.93,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_ccb6a807aac733e7ac9a5015aa8f526a"}],"concepts":[{"public_id":"co_06c781f15d0d2df435d83a0100f630ae","status":"active","name":"epidermal growth factor receptor variant III-positive tumors","description":"Glioblastoma tumors classified as containing epidermal growth factor receptor variant III.","types":["tumor group"],"aliases":["EGFRvIII-positive tumors"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_06c781f15d0d2df435d83a0100f630ae"},{"public_id":"co_1b858dd5071b92773812a642b787203f","status":"active","name":"epidermal growth factor receptor variant III status","description":"The classification of tumors according to the presence or absence of epidermal growth factor receptor variant III.","types":["molecular status"],"aliases":["EGFRvIII status"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_1b858dd5071b92773812a642b787203f"},{"public_id":"co_29b13259a532eee929df5f433511e6ba","status":"active","name":"relative plasma volume","description":"A normalized dynamic contrast-enhanced MR imaging perfusion parameter reflecting tumor plasma volume.","types":["perfusion parameter"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_29b13259a532eee929df5f433511e6ba"},{"public_id":"co_3b72a6f655c3c772c48613635b19df9d","status":"active","name":"relative contrast transfer coefficient","description":"A normalized dynamic contrast-enhanced MR imaging parameter reflecting contrast transfer or leakiness.","types":["perfusion parameter"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_3b72a6f655c3c772c48613635b19df9d"},{"public_id":"co_54329904def3de3170d897ca8847edd5","status":"active","name":"dynamic contrast-enhanced MR imaging perfusion parameters","description":"Quantitative measures derived from dynamic contrast-enhanced MR imaging perfusion maps.","types":["measurement"],"aliases":["DCE MR imaging perfusion parameters"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_54329904def3de3170d897ca8847edd5"},{"public_id":"co_62b0dd5a640a4443b1cf800981f6b14f","status":"active","name":"glioblastoma","description":"The malignant brain tumor type studied in the patient cohort.","types":["disease"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_62b0dd5a640a4443b1cf800981f6b14f"},{"public_id":"co_79e968b1281f5f22981a0a3f824834a0","status":"active","name":"positive epidermal growth factor receptor variant III status","description":"The tumor classification indicating presence of epidermal growth factor receptor variant III.","types":["molecular status"],"aliases":["EGFRvIII-positive status"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_79e968b1281f5f22981a0a3f824834a0"},{"public_id":"co_8e8cdc125a1a7302e6ca631e12e52095","status":"active","name":"epidermal growth factor receptor variant III-negative tumors","description":"Glioblastoma tumors classified as lacking epidermal growth factor receptor variant III.","types":["tumor group"],"aliases":["EGFRvIII-negative tumors"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_8e8cdc125a1a7302e6ca631e12e52095"},{"public_id":"co_be162443834d5d27af6e9513b2f150e2","status":"active","name":"dynamic contrast-enhanced MR imaging","description":"A T1-weighted MRI perfusion technique used before surgery to measure tumor vascular properties.","types":["imaging method"],"aliases":["DCE MR imaging","dynamic contrast-enhanced MRI"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_be162443834d5d27af6e9513b2f150e2"},{"public_id":"co_c09695e7da8335adc8b0faa87a1a0602","status":"active","name":"relative contrast transfer coefficient histogram metrics","description":"Histogram-derived summary values for relative contrast transfer coefficient within enhancing tumor volumes.","types":["imaging metric"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_c09695e7da8335adc8b0faa87a1a0602"},{"public_id":"co_d091e2f003308b280fac97362007de45","status":"active","name":"epidermal growth factor receptor variant III","description":"A mutation in glioblastoma assessed as a molecular tumor marker in this paper.","types":["mutation","biomarker"],"aliases":["EGFRvIII","epidermal growth factor receptor vIII"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_d091e2f003308b280fac97362007de45"},{"public_id":"co_ff2f0be86c92720697b5d5121435b54d","status":"active","name":"relative plasma volume histogram metrics","description":"Histogram-derived summary values for relative plasma volume within enhancing tumor volumes.","types":["imaging metric"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_ff2f0be86c92720697b5d5121435b54d"}],"external_ids":{"DOI":"10.3174/ajnr.A4484","ArXiv":null,"PubMed":26338913,"PubMedCentral":"PMC4724408","MAG":1852426414,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"http://www.ajnr.org/content/ajnr/36/12/2256.full.pdf","landing_url":"https://www.semanticscholar.org/paper/d4778ca52e386097d42372e9948da62359c69975","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":630630,"paper_uid":"e37ea03c-bb70-4fc4-8098-24589148a71b","canonical_identity":{"paper_id":630630,"paper_uid":"e37ea03c-bb70-4fc4-8098-24589148a71b","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/30447140"}